FDA Approves New Drug Rasonque to Treat Advanced Pancreatic Cancer The US Food and Drug Administration's (FDA) approval of Revolution Medicines' Rasonque is a significant breakthrough in the treatment of advanced pancreatic cancer.
This development has sparked hope for patients and raised questions about access and affordability.
Rasonque's unique mechanism of action involves blocking several forms of the RAS protein, which plays a key role in tumour growth.